Podcast: Centenarians, protective genes and geroscience with Dr. Nir Barzilai
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedIn this podcast description, Dr. Nir Barzilai discusses studies of centenarians and protective genes that may delay aging and age-related diseases, plus gerotherapeutics such as metformin; the video and transcript were not reviewed. [1]
The description says some people live beyond 100 despite smoking, being overweight and never following a perfect health routine. [1]
The description attributes to Dr. Barzilai research on protective genes that may delay aging and age-related diseases in centenarians. [1]
The description says growth hormone and IGF-1 may have very different effects on aging depending on biological age. [1]
Centenarians with bad habits and protective genes
The description says some people live beyond 100 despite smoking, being overweight and never following a perfect health routine. It attributes to Dr. Barzilai research on protective genes that help delay aging and age-related diseases in centenarians. It presents exceptional longevity as not only a matter of diet, exercise or supplements. These are claims made in the description, not results reviewed here. [1]
Metformin, peptides and other gerotherapeutics discussed
According to the description, the episode covers metformin, GLP-1 drugs, SGLT2 inhibitors and other gerotherapeutics intended to target the biology of aging rather than individual diseases. It also mentions the TAME trial, described as investigating metformin's effects on aging, and the science behind MOTS-c and Humanin peptides. The description also says the risks of unregulated peptide injections and the evidence on hyperbaric oxygen therapy, stem cells and biological age testing are discussed. No outcomes are reported in the description. [1]
Growth hormone, IGF-1 and compressing late-life illness
The description says growth hormone and IGF-1 may have very different effects on aging depending on biological age. It frames the goal of longevity science not as living forever but as compressing illness into the shortest possible period at the end of life. These are topics announced for the episode; the description gives no study design, sample or measured outcomes. [1]
Context & limits
Only the video description was available; the video and transcript were not reviewed. The description announces topics and names a trial but reports no study design, sample, follow-up or measured outcomes, so no effect of any drug, peptide or therapy is established here.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
live beyond 100 despite smoking, being overweight
protective genes that help delay aging
depending on our biological age
About this video
Creator description · original textText language: Turkish
Ayık Kafa · 2 min · Source published: 2026-10-17
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.